Correlation Between Neuropace and Perspective Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neuropace and Perspective Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Perspective Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Perspective Therapeutics, you can compare the effects of market volatilities on Neuropace and Perspective Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Perspective Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Perspective Therapeutics.
Diversification Opportunities for Neuropace and Perspective Therapeutics
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Neuropace and Perspective is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Perspective Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Perspective Therapeutics and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Perspective Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Perspective Therapeutics has no effect on the direction of Neuropace i.e., Neuropace and Perspective Therapeutics go up and down completely randomly.
Pair Corralation between Neuropace and Perspective Therapeutics
Given the investment horizon of 90 days Neuropace is expected to generate 0.59 times more return on investment than Perspective Therapeutics. However, Neuropace is 1.69 times less risky than Perspective Therapeutics. It trades about 0.26 of its potential returns per unit of risk. Perspective Therapeutics is currently generating about -0.26 per unit of risk. If you would invest 693.00 in Neuropace on August 31, 2024 and sell it today you would earn a total of 332.00 from holding Neuropace or generate 47.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neuropace vs. Perspective Therapeutics
Performance |
| Timeline |
| Neuropace |
| Perspective Therapeutics |
Neuropace and Perspective Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neuropace and Perspective Therapeutics
The main advantage of trading using opposite Neuropace and Perspective Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Perspective Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Perspective Therapeutics will offset losses from the drop in Perspective Therapeutics' long position.| Neuropace vs. Abbott Laboratories | Neuropace vs. Medtronic PLC | Neuropace vs. Edwards Lifesciences Corp | Neuropace vs. ZimVie Inc |
| Perspective Therapeutics vs. Orthopediatrics Corp | Perspective Therapeutics vs. Orthofix Medical | Perspective Therapeutics vs. Sight Sciences | Perspective Therapeutics vs. Neuropace |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |